Conduct of clinical trials in developing countries: A perspective

Current Opinion in Cardiology

Volumn 24, Issue 4, 2009, Pages 295-300

  Devasenapathy, Niveditha ^a   Singh, Kavita ^a   Prabhakaran, Dorairaj ^a  

^a CENTRE FOR CHRONIC DISEASE CONTROL   (India)

Author keywords

Clinical trials; Developing countries; Ethics

Indexed keywords

CHINA; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG SAFETY; FUNDING; GOOD CLINICAL PRACTICE; HEALTH CARE SYSTEM; INDIA; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; PERSONNEL MANAGEMENT; POVERTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TANZANIA; CLINICAL TRIAL (TOPIC); HUMAN; PROCEDURES; RESEARCH; RESEARCH ETHICS;

CLINICAL TRIALS AS TOPIC; DEVELOPING COUNTRIES; ETHICS, RESEARCH; HUMANS; INFORMED CONSENT; RESEARCH;

EID: 67651162025     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32832af21b     Document Type: Review

References (27)

1. Garrafa V, Lorenzo C. Moral imperialism and multicentric clinical trials in peripheral countries. Cad Saude Publica 2008; 24:2219-2226. This review article critically analyses the expression 'moral imperialism' applying to multicentric clinical trials performed in developing countries funded by the west. The authors also propose the development of a system for the regulation and social auditing of research in poor and developing countries.
2. Workshop on Clinical Trials Capacity in Low- and Middle-Income Countries: experiences, lessons learned and priorities for strengthening initiative on public-private partnerships for health, global forum for health research. Published by The Initiative on Public-Private Partnerships for Health, Global Forum for Health Research, March 2004. Available at http://www. globalforumhealth. org/filesupld/ippph-cd/02.PDF. [Accessed 20 October 2008]
3. World Bank, Data and Statistics. Available at: http://web.worldbank.org/ WBSITE/EXTERNAL/DATASTATISTICS/0,contentMDK:20420458~menu PK:64133156~pagePK: 64133150~piPK:64133175~theSitePK:239419, 00.html. [Accessed 20 October 2008]
4. Opinion of the European group on ethics in science and new technologies to the European commission. Available at: http://ec.europa.eu/european- group-ethics/docs/avis11-en.pdf. [Accessed 20 October 2008]
5. The 10/90 report on health research 2000. Geneva: Global Forum for Health Research; 2000.
6. WHOAd-Hoc Committee on Health Research Relating to Future Intervention Options. Investing in Health Research and Development. Geneva: World Health Organization; 1996.
7. Prabhakaran P, Ajay VS, Prabhakaran D, et al. Global cardiovascular disease research survey. J Am Coll Cardiol 2007; 50:2322-2328. (Pubitemid 350192099)
8. Nundy S,Gulhati CM. A new colonialism? Conducting clinical trials in India. N Engl J Med 2005; 352:1633-1636. (Pubitemid 40530229)
9. Mendis S, Abegunde D, Yusuf S, et al. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull World Health Organ 2005; 83:820-829. (Pubitemid 41624867)
10. Xavier D, Pais P, Devereaux PJ, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008; 371:1435-1442. (Pubitemid 351601890)
11. Yusuf S. Clinical research and trials in developing countries. Stat Med 2002; 21:2859-2867.
12. Frimpong-Mansoh A. Culture and voluntary informed consent in African healthcare System. Dev World Bioeth 2008; 8:104-114.
13. Castillo FA. Limiting factors impacting on voluntary first person informed consent in the Philippines. Dev World Bioeth 2002; 2:11-20.
14. Lynoe N, Hyder Z, Chowdhury M, Ekstrom L. Obtaining informed consent in Bangladesh. N Engl J Med 2001; 344:460-461.
15. Angell M. Investigators' responsibilities for human subjects in developing countries. N Engl J Med 2000; 342:967-969. (Pubitemid 30177058)
16. Hill Z, Tawiah-Agyemang C, Odei-Danso S, Kirkwood B. Informed consent in Ghana: what do participants really understand? J Med Ethics 2008; 34:48-53.
17. Nair YM, Martin DK. Concerns about ethical review of health research in India. Indian J Med Ethics 2004; 1:119-120.
18. Beckford L, Broome MR. Ethics and the payment of research subjects. Psychiatry 2007; 6:83-85.
19. Zong Z. Should posttrial provision of beneficial experimental interventions be mandatory in developing countries? J Med Ethics 2008; 34:188-192.
20. Grimes DA, Hubacher D, Nanda K, et al. The good clinical practice guideline: a bronze standard for clinical research. Lancet 2005; 366:172-174. (Pubitemid 40991220)
21. Ananworanich J, Cheunyam T, Teeratakulpisarn S, et al. Creation of a drug fund for postclinical trial access to antiretrovirals. Lancet 2004; 364:101-102. (Pubitemid 38968631)
22. Singer PA, Benatar SR. Beyond Helsinki: a vision for global health ethics. BMJ 2001; 322:747-748.
23. Ravindran GD. Medical ethics education in India. Indian J Med Ethics 2008; 5:18-19.
24. Silverman H. Enhancing research ethics capacity: implications for protection of research subjects, avoiding exploitation and achieving global health. Middle East Fertil Soc J 2005; 10:105-109. (Pubitemid 41445104)
25. Studdert DM, Brennan TA. Clinical trials in developing countries: scientific and ethical issues. Med J Aust 1998; 169:545-548. (Pubitemid 28521268)
26. Benatar SR, Singer PA. A new look at international research ethics. BMJ 2000; 321:824-826. (Pubitemid 30760388)
27. Page J, Heller RF, Kinlay S, et al. Attitudes of developing world physicians to where medical research is performed and reported. BMC Public Health 2003; 3:6. (Pubitemid 38809166)